← Back

Wire · opportunities

'This could be transformative': Surgeon performs first US implant of heart valve still under FDA review

Published

2 September 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at cardiovascularbusiness.com

Verified

Fusion42 · 3 September 2026 · Fusion42 review

A pediatric heart surgery team at University of Michigan performed the first US implant of the Autus Valve, a size-adjustable pulmonary valve designed to grow with children, still under FDA review. The device aims to reduce repeat surgeries for children with heart valve issues and is under close FDA observation.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

The FDA’s ongoing review means you should prepare for rapid changes in device approvals that could open US paediatric cardiac markets. This implant sets a precedent—your closest hospital or device partner could be next to use a game-changing valve that cuts repeat surgeries.

Coverage

1 source · 2 Sep 2026

Related on Wire

Topics

Medtechpediatric-cardiac-surgeryfda-reviewmedtech-innovationheart-valveminimally-invasive